Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)
China flag China · Delayed Price · Currency is CNY
13.45
+0.08 (0.60%)
Apr 28, 2026, 3:04 PM CST

SHE:002675 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
820.2871.93757.01644.421,022826.61
Trading Asset Securities
172.68225.22148.5420.1227.33129.27
Cash & Short-Term Investments
992.881,097905.55664.531,049955.88
Cash Growth
18.46%21.16%36.27%-36.65%9.74%14.64%
Accounts Receivable
1,041989.89936.24794.08883.53875.48
Other Receivables
21.15.050.6510.9662.1319.06
Receivables
1,062994.94936.89805.04945.66894.55
Inventory
494.22532.57646.22903.861,078952.53
Other Current Assets
64.8960.2878.99104.25120.0596.81
Total Current Assets
2,6142,6852,5682,4783,1932,900
Property, Plant & Equipment
2,6252,6292,3352,1471,9641,616
Long-Term Investments
383.83383.91356.05212.92191.1243.37
Goodwill
2,4842,4912,5012,5442,3302,373
Other Intangible Assets
275.04281.68252.54219.44226.06191.41
Long-Term Deferred Tax Assets
144.27134.6694.8988.0363.7158.61
Long-Term Deferred Charges
461.79444.73363.02243133.24177.03
Other Long-Term Assets
191.24173.43164.82150.3776.6996.54
Total Assets
9,1799,2248,6358,0828,1777,656
Accounts Payable
523.92583.93588.41876.021,3321,052
Accrued Expenses
97.03337.36281.49240.55255.3216.99
Short-Term Debt
246.61252490.23372.97391.47365.96
Current Portion of Long-Term Debt
95.5668.4464.65147.646.66156.37
Current Portion of Leases
-18.149.3411.394.993.69
Current Income Taxes Payable
89.9657.4947.9653.4656.6136.14
Current Unearned Revenue
101.6887.1106.01114.25108.8268.47
Other Current Liabilities
376.33231.55165.87135.48197.72143.11
Total Current Liabilities
1,5311,6361,7541,9522,3932,043
Long-Term Debt
375.55297.33301.86249.21232.6520.36
Long-Term Leases
141.1140.433.8811.077.532.89
Long-Term Unearned Revenue
197.43192.28196.79236.97240.2747.33
Long-Term Deferred Tax Liabilities
25.0422.6917.4118.118.6316.76
Other Long-Term Liabilities
1,5041,471959.32219.662.222.22
Total Liabilities
3,7753,7603,2632,6872,8952,633
Common Stock
824.6824.6824.6824.6824.6802.21
Additional Paid-In Capital
1,7001,7001,9982,3412,4022,317
Retained Earnings
1,8471,8141,6431,6031,5171,290
Comprehensive Income & Other
-0.2411.8114.846.864.84-11.78
Total Common Equity
4,2864,3504,4804,7754,7494,397
Minority Interest
1,1181,114891.02620.22533.66626.35
Shareholders' Equity
5,4045,4645,3715,3965,2825,024
Total Liabilities & Equity
9,1799,2248,6358,0828,1777,656
Total Debt
858.82776.32899.96792.23683.251,049
Net Cash (Debt)
134.06320.835.59-127.7365.7-93.39
Net Cash Growth
276.05%5638.53%----
Net Cash Per Share
0.160.390.01-0.150.45-0.12
Filing Date Shares Outstanding
824.6824.6824.6824.6824.6802.21
Total Common Shares Outstanding
824.6824.6824.6824.6824.6802.21
Working Capital
1,0831,049813.69525.96799.34856.82
Book Value Per Share
5.205.285.435.795.765.48
Tangible Book Value
1,5271,5771,7272,0122,1931,833
Tangible Book Value Per Share
1.851.912.092.442.662.28
Buildings
-1,6171,4901,1961,119869.32
Machinery
-1,2911,162943.15870.18747.8
Construction In Progress
-639.8567.91780.03641.37561.05
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.